EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC

EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC

Show other versions (1)

Solvay pharma expands its product portfolio, by launching alfa normix (rifaximin) for the treatment of the gastroenteric infections. Alfa normix is a non-systemic broad-spectrum antibiotic to treat acute gastroenteric infections and is prescribed for the travelers suffering from diarrhea, the overgr...

Full description

Bibliographic Details
Main Author: article editorial
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2008-05-01
Series:Pediatričeskaâ Farmakologiâ
Online Access:https://www.pedpharma.ru/jour/article/view/868
id doaj-0e16dfff6e6442b3bb769f501a4b82a1
record_format Article
spelling doaj-0e16dfff6e6442b3bb769f501a4b82a12021-07-28T16:32:33ZengPaediatrician Publishers, LLCPediatričeskaâ Farmakologiâ1727-57762500-30892008-05-0153120128863EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTICarticle editorialSolvay pharma expands its product portfolio, by launching alfa normix (rifaximin) for the treatment of the gastroenteric infections. Alfa normix is a non-systemic broad-spectrum antibiotic to treat acute gastroenteric infections and is prescribed for the travelers suffering from diarrhea, the overgrowth of microorganisms in the intestinal tract, hepatic encephalopathy, symptomatic uncomplicated diverticular disease of the segmented intestine, and chronic inflammation of the intestinal tract, as well as to prevent the infectious complications in the event of the colorectal surgeries. The first medication deliveries to Russia are scheduled for march 2008.Key words: rifaximin, infectious diarrhea, enteric infections.https://www.pedpharma.ru/jour/article/view/868
collection DOAJ
language English
format Article
sources DOAJ
author article editorial
spellingShingle article editorial
EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
Pediatričeskaâ Farmakologiâ
author_facet article editorial
author_sort article editorial
title EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
title_short EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
title_full EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
title_fullStr EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
title_full_unstemmed EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
title_sort experimental and clinical pharmacology of rifaximin selective enteric antibiotic
publisher Paediatrician Publishers, LLC
series Pediatričeskaâ Farmakologiâ
issn 1727-5776
2500-3089
publishDate 2008-05-01
description Solvay pharma expands its product portfolio, by launching alfa normix (rifaximin) for the treatment of the gastroenteric infections. Alfa normix is a non-systemic broad-spectrum antibiotic to treat acute gastroenteric infections and is prescribed for the travelers suffering from diarrhea, the overgrowth of microorganisms in the intestinal tract, hepatic encephalopathy, symptomatic uncomplicated diverticular disease of the segmented intestine, and chronic inflammation of the intestinal tract, as well as to prevent the infectious complications in the event of the colorectal surgeries. The first medication deliveries to Russia are scheduled for march 2008.Key words: rifaximin, infectious diarrhea, enteric infections.
url https://www.pedpharma.ru/jour/article/view/868
work_keys_str_mv AT articleeditorial experimentalandclinicalpharmacologyofrifaximinselectiveentericantibiotic
_version_ 1721265833005547520

Similar Items